BiotechTube
OXON

OXON

Barcelona, Spain· Est.
oxonepi.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

OXON is a specialized, service-based CRO focused on the high-growth Real-World Evidence (RWE) and late-phase clinical research market. Leveraging strong academic links and a global operational network, it delivers observational studies, post-approval research, and evidence synthesis to support regulatory and market access decisions for its clients. The company has established itself as a preferred provider for several large pharmaceutical companies, indicating a strong reputation for quality and scientific rigor in its niche.

EpigeneticsOncology

Technology Platform

Integrated RWE service methodology encompassing primary data collection, secondary data analysis, hybrid studies, evidence synthesis, and advanced biostatistics/modeling.

Opportunities

Growing regulatory and payer demand for Real-World Evidence creates a large and expanding market.
Specialization in complex areas like orphan diseases, hybrid studies, and pragmatic trials allows OXON to address high-value niches.
Strong academic partnerships enhance scientific credibility and attract clients needing rigorous study designs.

Risk Factors

Faces intense competition from both large global CROs and smaller niche players in the RWE space.
Revenue is entirely dependent on winning service contracts, creating vulnerability to biopharma outsourcing cycles.
Evolving regulatory standards for RWE require continuous investment in methodological expertise to maintain service relevance.

Competitive Landscape

OXON competes in the specialized RWE and late-phase CRO segment against large, diversified CROs (e.g., IQVIA, Parexel) with broader scale and smaller, agile niche firms. Its differentiation is based on a strong scientific/academic foundation, a focus on complex observational study designs, and positioning as a preferred provider for specific big pharma clients.

More companies in Digital Health & Biotech SaaS →More companies in Spain →